Overview

The Feasibility of Florbetapir Quantitation

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
0
Participant gender:
All
Summary
The overall objective of the study is to assess the feasibility of implementing a quantitative process of florbetapir F 18 scan interpretation. The hypothesis is that the use of quantitative analysis will increase the accuracy of florbetapir F 18 scan interpretation.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Avid Radiopharmaceuticals
Criteria
Inclusion Criteria:

- Readers have undergone Amyvid reader training

- Readers have minimal experience with quantitation of amyloid PET scans

Exclusion Criteria:

- Readers have previously been trained to quantitate amyloid PET scans